SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company. It offers SOMAmers (Slow-Offrate Modified Aptamers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and SOMAscan that provides protein detection and equipment. The company’s SOMAmer/SOMAscan technology enables to discover protein biomarker signatures; drug discovery and development; and clinical diagnostics. Its products have applications in the diagnostics of various diseases in oncology, neurology, cardiovascular and metabolic disease, and other diseases and conditions. SomaLogic, Inc. was founded in 1999 and is headquartered in Boulder, Colorado.

Company Growth (employees)
Type
Private
HQ
Boulder, US
Founded
2000
Size (employees)
197 (est)+3%
SomaLogic was founded in 2000 and is headquartered in Boulder, US

Key People at SomaLogic

Larry Gold

Larry Gold

Chairman and CEO
Scott Kothlow

Scott Kothlow

CFO
Stephen A. Williams

Stephen A. Williams

Chief Medical Officer
Nebojsa Janjic

Nebojsa Janjic

Chief Science Officer

SomaLogic Office Locations

SomaLogic has an office in Boulder
Boulder, US (HQ)
2945 Wilderness Pl

SomaLogic Metrics

Summary Metrics

Founding Date

2000

Total Funding

$179.5 m

Latest funding size

$60.5 m

Time since last funding

about 1 year

Investors

SomaLogic's latest funding round in March 2016 was reported to be $60.5 m. In total, SomaLogic has raised $179.5 m

SomaLogic Online Presence

SomaLogic Company Life

You may also be interested in